2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 0 | 673 | 1.430 | 1.316 | 1.096 | 896 | 282 | 0 | 0 | 0 |
Total Income - EUR | 0 | 673 | 1.430 | 1.316 | 1.096 | 896 | 282 | 1.314 | 0 | 0 |
Total Expenses - EUR | 113 | 2.942 | 1.423 | 690 | 1.095 | 928 | 605 | 1.743 | 12 | 44 |
Gross Profit/Loss - EUR | -113 | -2.270 | 6 | 626 | 1 | -32 | -323 | -429 | -12 | -44 |
Net Profit/Loss - EUR | -113 | -2.290 | -37 | 586 | -32 | -59 | -331 | -469 | -12 | -44 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alesor Rx S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 3.694 | 3.507 | 3.103 | 2.688 | 2.283 | 1.891 | 1.513 | 0 | 0 | 0 |
Current Assets | 767 | 22 | 3 | 22 | 364 | 154 | 388 | 178 | 166 | 52 |
Inventories | 335 | 0 | 0 | 0 | 0 | 72 | 70 | 69 | 69 | 0 |
Receivables | 415 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 17 | 22 | 3 | 22 | 364 | 82 | 318 | 109 | 97 | 52 |
Shareholders Funds | -68 | -2.359 | -2.371 | -1.745 | -1.745 | -1.770 | -2.067 | -2.489 | -2.509 | -2.546 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 4.529 | 5.889 | 5.478 | 4.455 | 4.392 | 3.814 | 3.968 | 2.667 | 2.675 | 2.598 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Alesor Rx S.r.l.